2024 Q3 Form 10-Q Financial Statement

#000121390024070805 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $37.26K $27.59K $7.460K
YoY Change -28.27% -52.96% -88.25%
Cost Of Revenue $58.56K $5.940K $786.9K
YoY Change 17.26% -88.13% 986.55%
Gross Profit -$21.30K $21.65K -$779.4K
YoY Change -1161.29% 151.85% 8618.34%
Gross Profit Margin -57.17% 78.47% -10447.99%
Selling, General & Admin $186.5K $73.31K
YoY Change 3.0% -70.8%
% of Gross Profit 861.27%
Research & Development $40.78K $132.0K $205.2K
YoY Change 193.62% 169.81% 34.88%
% of Gross Profit 609.68%
Depreciation & Amortization $26.09K $38.36K
YoY Change -3.12% 165.1%
% of Gross Profit 120.49%
Operating Expenses $172.8K $318.5K $278.5K
YoY Change -36.78% 38.49% -30.93%
Operating Profit -$194.1K -$296.9K -$1.058M
YoY Change -28.46% 34.09% 156.68%
Interest Expense $71.27K $0.00
YoY Change 3844.11% -100.0%
% of Operating Profit
Other Income/Expense, Net -$83.79K $71.27K
YoY Change -9472.93% -4043.88%
Pretax Income -$277.9K -$225.6K -$1.058M
YoY Change 2.76% 1.08% 153.21%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$277.9K -$225.6K -$1.058M
YoY Change 2.76% 1.08% 10.83%
Net Earnings / Revenue -745.86% -817.57% -14181.64%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.509B shares 1.462B shares 1.462B shares
Diluted Shares Outstanding 1.511B shares 1.472B shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $698.7K $719.1K
YoY Change -35.44% -60.96%
Cash & Equivalents $534.7K $698.7K $719.1K
Short-Term Investments
Other Short-Term Assets $13.00K $15.90K $8.710K
YoY Change 73.33% 6.0%
Inventory $30.11K $79.62K $99.15K
Prepaid Expenses $3.500K
Receivables $16.29K $10.29K $9.030K
Other Receivables $0.00 $0.00
Total Short-Term Assets $597.6K $804.5K $836.0K
YoY Change -67.49% -61.39% -71.27%
LONG-TERM ASSETS
Property, Plant & Equipment $106.9K $128.9K $360.3K
YoY Change -49.12% -41.07% 161.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $212.5K $261.9K $370.3K
YoY Change -50.5% -44.19% -17.92%
TOTAL ASSETS
Total Short-Term Assets $597.6K $804.5K $836.0K
Total Long-Term Assets $212.5K $261.9K $370.3K
Total Assets $810.1K $1.066M $1.206M
YoY Change -64.28% -58.23% -64.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.58K $101.2K $37.00K
YoY Change 176.7% 621.68% -32.54%
Accrued Expenses $46.00K $6.426K $194.9K
YoY Change -73.92% -95.93% -17.17%
Deferred Revenue $36.00K
YoY Change
Short-Term Debt $78.61K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $176.5K $493.9K $231.9K
YoY Change -8.14% 187.1% -51.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $43.68K
YoY Change -75.49%
Total Long-Term Liabilities $43.68K
YoY Change -75.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $176.5K $493.9K $231.9K
Total Long-Term Liabilities $43.68K
Total Liabilities $176.5K $493.9K $275.6K
YoY Change -36.75% 67.91% -57.75%
SHAREHOLDERS EQUITY
Retained Earnings -$14.95M -$14.67M -$14.19M
YoY Change 13.81% 14.04% 14.32%
Common Stock $1.518M $1.482M $1.462M
YoY Change 3.87% 1.43% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $633.6K $572.5K $930.7K
YoY Change
Total Liabilities & Shareholders Equity $810.1K $1.066M $1.206M
YoY Change -64.28% -58.23% -64.11%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$277.9K -$225.6K -$1.058M
YoY Change 2.76% 1.08% 10.83%
Depreciation, Depletion And Amortization $26.09K $38.36K
YoY Change -3.12% 165.1%
Cash From Operating Activities -$151.9K -$173.6K
YoY Change -49.93% -36.03%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $11.67K
YoY Change -77.03%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$11.67K
YoY Change -77.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 120.0K 0.000
YoY Change -251.53% -100.0%
NET CHANGE
Cash From Operating Activities -151.9K -173.6K
Cash From Investing Activities 0.000 -11.67K
Cash From Financing Activities 120.0K 0.000
Net Change In Cash -31.89K -185.3K
YoY Change -91.66% -41.92%
FREE CASH FLOW
Cash From Operating Activities -$151.9K -$173.6K
Capital Expenditures $0.00 $11.67K
Free Cash Flow -$151.9K -$185.3K
YoY Change -49.93% -42.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-53450
dei Entity Registrant Name
EntityRegistrantName
REMSLEEP HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5386867
dei Entity Address Address Line1
EntityAddressAddressLine1
14175 Icot Boulevard,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Clearwater
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33760
dei Local Phone Number
LocalPhoneNumber
912-590-2001
dei City Area Code
CityAreaCode
912
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
RMSL
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1508905448 shares
CY2024Q2 us-gaap Cash
Cash
698727 usd
CY2023Q4 us-gaap Cash
Cash
719100 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5590 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5590 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10294 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9025 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
15900 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8710 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
79617 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
99147 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
804538 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
835982 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
122996 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
177796 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128891 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
182536 usd
CY2024Q2 us-gaap Assets
Assets
1066425 usd
CY2023Q4 us-gaap Assets
Assets
1206314 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
101187 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
37000 usd
CY2024Q2 rmsl Accrued Compensation Current
AccruedCompensationCurrent
52500 usd
CY2023Q4 rmsl Accrued Compensation Current
AccruedCompensationCurrent
60500 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
64392 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
78608 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
97065 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6426 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
36000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122118 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
134438 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
493904 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
231938 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43676 usd
CY2024Q2 us-gaap Liabilities
Liabilities
493904 usd
CY2023Q4 us-gaap Liabilities
Liabilities
275614 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1482455943 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1482455943 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1461616601 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1461616601 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1482455 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1461615 usd
CY2024Q2 rmsl Discount To Common Stock
DiscountToCommonStock
94708 usd
CY2023Q4 rmsl Discount To Common Stock
DiscountToCommonStock
94708 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13848212 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13749052 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14670938 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14192759 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
572521 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
930700 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1066425 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1206314 usd
CY2024Q2 us-gaap Revenues
Revenues
27594 usd
CY2023Q2 us-gaap Revenues
Revenues
58660 usd
us-gaap Revenues
Revenues
85475 usd
us-gaap Revenues
Revenues
144315 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
5940 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
50062 usd
us-gaap Cost Of Revenue
CostOfRevenue
19530 usd
us-gaap Cost Of Revenue
CostOfRevenue
123638 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
21654 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
8598 usd
us-gaap Gross Profit
GrossProfit
65945 usd
us-gaap Gross Profit
GrossProfit
20677 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
56715 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
29810 usd
us-gaap Professional Fees
ProfessionalFees
64685 usd
us-gaap Professional Fees
ProfessionalFees
47702 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
33812 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
52000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
56000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
112000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
132020 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48930 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156020 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
75712 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
22016 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
23195 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
50924 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
69499 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73956 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76054 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
159396 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158131 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
318519 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
229989 usd
us-gaap Operating Expenses
OperatingExpenses
487025 usd
us-gaap Operating Expenses
OperatingExpenses
463044 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-296865 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-221391 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-421080 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-442367 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
32932 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1807 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
60911 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7090 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-104198 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3812 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
71266 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1807 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57099 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7090 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225599 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-223198 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-478179 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-449457 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-225599 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-223198 usd
us-gaap Net Income Loss
NetIncomeLoss
-478179 usd
us-gaap Net Income Loss
NetIncomeLoss
-449457 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1472446044 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1461616601 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1467031323 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1461616601 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
930700 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-252580 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
678120 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
120000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-225599 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
572521 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2708538 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-226259 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2482279 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-223198 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2259081 usd
us-gaap Net Income Loss
NetIncomeLoss
-478179 usd
us-gaap Net Income Loss
NetIncomeLoss
-449457 usd
us-gaap Depreciation
Depreciation
53645 usd
us-gaap Depreciation
Depreciation
47704 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3812 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
54485 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1196 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17378 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1269 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39069 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7190 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-19530 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-120041 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64187 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-40824 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
36000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-8000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
2000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6426 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-90119 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-265373 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-447346 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
128450 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128450 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
125000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
120000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
183931 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
245000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183931 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-20373 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-759727 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
719100 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1841988 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
698727 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1082261 usd
rmsl Debt Discount To Be Amortized
DebtDiscountToBeAmortized
64392 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2007-06-06
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration:underline">Use of Estimates </span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). As of June 30, 2024 and December 31, 2023, the Company had $448,727 and $469,100 of cash above the FDIC’s $250,000 coverage limit, respectively.</p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
448727 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
469100 usd
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2024Q2 rmsl Fixed Asset
FixedAsset
2000 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y
rmsl Total Number Of Units Sold
TotalNumberOfUnitsSold
1000 shares
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5590 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
738113 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14670938 usd
us-gaap Net Income Loss
NetIncomeLoss
-478179 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-265373 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
206499 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
152854 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128891 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
182536 usd
us-gaap Depreciation
Depreciation
53645 usd
us-gaap Depreciation
Depreciation
47704 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
143000 usd
us-gaap Legal Fees
LegalFees
5000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
118887 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
100877 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
54485 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
100877 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3812 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
97065 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company entered into a Lease Agreement (the “Lease”) with 14175 Icot Blvd, LLC (the “Lessor”), effective May 1, 2022, relating to approximately 9,677 square feet of property located at 14175 Icot Blvd, Clearwater, FL 33760.
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
8686.71 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
9034.17 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
12287.63 usd
CY2024Q2 us-gaap Prepaid Rent
PrepaidRent
69494 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
76416 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
49151 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
125567 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3449 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
122118 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
50924 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
45578 usd
us-gaap Interest Expense Operating
InterestExpenseOperating
5346 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
69500 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
43613 usd
CY2023Q2 us-gaap Prepaid Rent
PrepaidRent
18298 usd
us-gaap Interest Expense Operating
InterestExpenseOperating
7589 usd
us-gaap Payments For Rent
PaymentsForRent
11095 usd
CY2024Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
rmsl Percentage Of Common Stock Issued And Outstanding
PercentageOfCommonStockIssuedAndOutstanding
0.81 pure
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
250000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1461616601 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1461616601 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1467031323 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1472446044 shares
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
rmsl Debt Discount To Be Amortized
DebtDiscountToBeAmortized
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
rmsl Increase Decrease To Derivative Due To Conversion
IncreaseDecreaseToDerivativeDueToConversion
usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001412126

Files In Submission

Name View Source Status
0001213900-24-070805-index-headers.html Edgar Link pending
0001213900-24-070805-index.html Edgar Link pending
0001213900-24-070805.txt Edgar Link pending
0001213900-24-070805-xbrl.zip Edgar Link pending
ea0210905-10q_remsleep.htm Edgar Link pending
ea021090501ex31-1_remsleep.htm Edgar Link pending
ea021090501ex32-1_remsleep.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
ea0210905-10q_remsleep_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmsl-20240630.xsd Edgar Link pending
Show.js Edgar Link pending
rmsl-20240630_cal.xml Edgar Link unprocessable
rmsl-20240630_def.xml Edgar Link unprocessable
rmsl-20240630_lab.xml Edgar Link unprocessable
rmsl-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable